Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Dendritic Cell Immunotherapy Vs. Best Supportive Care As A Maintenance Treatment In UPM Patients Nov 14, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Lazertinib Is Effecive In NSCLC Patients With Uncommon EGFR Mutations Nov 14, 2023
Lung Cancer,SCLC (Small Cell Lung Cancer) Carboplatin, Etoposide, Bevacizumab, And Atezolizumab Regimen Well Tolerated In ES-SCLC Patients Nov 09, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Dato-DXd Vs. Docetaxel In Previously Treated Adv/Met NSCLC Nov 09, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Adjuvant Alectinib Improved DFS Versus Chemotherapy In ALK+ NSCLC Nov 09, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Real-World Outcomes Of Durvalumab After Chemo In Unresectable Stage III EGFR-Mutated NSCLC Nov 08, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Adagrasib Monotherapy Safe For Advanced/Metastatic KRASG12C-Mutated NSCLC Patients Nov 03, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) JDQ443 + TNO155 Show Preliminary Safety And Efficacy In Pts With Advanced, KRAS G12C-Mutated Solid Tumors Nov 02, 2023